NCT03448250 Evaluating a Novel Web-based Intervention for Breast Cancer Survivors Status TERMINATED Phase NA
NCT03447886 Understanding Barriers to Initiation and Adherence to Endocrine Therapy in Young Breast Cancer Survivors of Diverse Backgrounds Status COMPLETED Phase N/A
NCT03442543 Preoperative Localization of Sentinel Lymph Node in Breast Cancer Patients By Novel Computed Tomography-Lymphography Guided Technique Status UNKNOWN Phase PHASE1
NCT03442478 Comparison of Digital Breast Tomosynthesis to Conventional Mammography Status COMPLETED Phase NA
NCT03442127 Facilitating Oncology Patient-Clinician Communication Via E-health Innovations Status COMPLETED Phase NA
NCT03440398 Robotic Nipple-Sparing Mastectomy Vs Conventional Open Technique Status COMPLETED Phase NA
NCT03439735 Determinants of Resistance to Endocrine Therapy and a Cyclin-dependent Kinases 4 and 6 (CDK4/6) Inhibitor for HR+ MBC Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03439046 Study of the Molecular Features of Postmenopausal Women With HR+ HER2-negative aBC on First-line Treatment With Ribociclib and Letrozole and, in Patients With a PIK3CA Mutation, on Second-line Treatment With Alpelisib Plus Fulvestrant Status COMPLETED Phase PHASE3
NCT03437837 Validation of the CPS+EG, Neo-Bioscore and Modified Neo-Bioscore Staging Systems After PST of BC in China Status COMPLETED Phase N/A
NCT03437161 A Prospective Trial to Compare Deep Inspiratory Breath Hold (DIBH) With Prone Breast Irradiation Status COMPLETED Phase NA
NCT03435666 A Bioequivalence Study of Capecitabine Tablets 500 mg in Adult Cancer Patients Under Fed Condition Status UNKNOWN Phase PHASE1
NCT03433313 Efficacy and Safety Study of EG12014 Compared With Herceptin in Subjects With HER2 Positive Early Breast Cancer Status COMPLETED Phase PHASE3
NCT03432429 Real Time Tissue Characterisation Using Mass Spectrometry REI-EXCISE iKnife Study Status COMPLETED Phase N/A
NCT03430492 Sweden Cancerome Analysis Network - Breast (SCAN-B) Coupled to Psychological Resilience Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03430479 Anti PD-1 Antibody With Radiation Therapy in Patients With HER2-negative Metastatic Breast Cancer Status COMPLETED Phase PHASE1/PHASE2